New insights into antigen specific immunotherapy for chronic myeloid leukemia
<p>Abstract</p> <p>Chronic myeloid leukemia (CML) is a stem cell disease in which BCR/ABL plays an important role as an oncoprotein and a molecular and immunogenic target. Despite the success of targeted therapy using tyrosine kinase inhibitors (TKIs), CML remains largely incurable...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-12-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | http://www.cancerci.com/content/12/1/52 |